CRIS Current Research Information System

RAVAIOLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.936
NA - Nord America 7.829
EU - Europa 4.509
AF - Africa 549
SA - Sud America 450
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.683
VN - Vietnam 2.332
SG - Singapore 2.316
CN - Cina 2.174
IT - Italia 1.412
GB - Regno Unito 624
DE - Germania 553
HK - Hong Kong 546
SE - Svezia 430
IN - India 347
BR - Brasile 318
KR - Corea 318
BD - Bangladesh 269
NL - Olanda 262
FR - Francia 245
IE - Irlanda 186
JP - Giappone 176
RU - Federazione Russa 159
CI - Costa d'Avorio 152
ZA - Sudafrica 136
FI - Finlandia 118
SC - Seychelles 104
CA - Canada 78
AT - Austria 75
BG - Bulgaria 71
CH - Svizzera 66
ID - Indonesia 65
PH - Filippine 61
UA - Ucraina 58
TG - Togo 56
TH - Thailandia 55
PK - Pakistan 48
ES - Italia 46
AR - Argentina 45
NG - Nigeria 42
IQ - Iraq 39
MX - Messico 38
TR - Turchia 37
PL - Polonia 36
EE - Estonia 34
EC - Ecuador 31
JO - Giordania 31
TW - Taiwan 29
BE - Belgio 26
EG - Egitto 18
CL - Cile 14
HR - Croazia 13
SA - Arabia Saudita 13
GR - Grecia 12
LT - Lituania 12
PT - Portogallo 12
VE - Venezuela 12
AU - Australia 11
IR - Iran 11
RO - Romania 11
MY - Malesia 10
CO - Colombia 9
CR - Costa Rica 7
CZ - Repubblica Ceca 7
LB - Libano 7
PE - Perù 7
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
KE - Kenya 6
KZ - Kazakistan 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
MA - Marocco 5
NP - Nepal 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
MK - Macedonia 4
AZ - Azerbaigian 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
GA - Gabon 2
HN - Honduras 2
HU - Ungheria 2
LY - Libia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
UG - Uganda 2
Totale 22.264
Salva come PNG Salva come JPEG
Città #
Singapore 1.661
Ashburn 961
Fairfield 781
Hefei 622
Ho Chi Minh City 589
Hanoi 556
Southend 503
San Jose 496
Hong Kong 495
Chandler 415
Bologna 318
Seoul 280
New York 271
Santa Clara 266
Boardman 244
Beijing 242
Seattle 226
Woodbridge 217
Houston 191
Dublin 183
Los Angeles 183
Wilmington 183
Cambridge 173
Council Bluffs 168
Dallas 156
Princeton 156
Abidjan 152
Tokyo 142
Ann Arbor 125
Milan 120
Lauterbourg 109
Da Nang 102
Haiphong 88
Buffalo 86
Johannesburg 81
São Paulo 79
Frankfurt am Main 78
Rome 73
Munich 69
Sofia 69
Helsinki 66
Dong Ket 62
Bengaluru 59
Las Vegas 58
Lomé 56
Turin 56
Redondo Beach 55
Nanjing 49
Vienna 48
Redmond 46
Westminster 43
Florence 42
Berlin 41
Guangzhou 41
Bremen 39
Abeokuta 38
Shanghai 38
Bern 37
North Charleston 37
San Diego 37
Amsterdam 35
Phoenix 34
Brooklyn 33
Des Moines 31
Jakarta 31
Medford 31
Amman 30
Chicago 30
Orem 30
Redwood City 29
Turku 29
San Francisco 28
Boydton 27
Hải Dương 27
Biên Hòa 26
Dearborn 26
Hyderabad 26
Warsaw 26
Brussels 25
Falkenstein 25
Jinan 25
London 25
The Dalles 25
Can Tho 24
Nuremberg 24
Bangkok 23
Bến Tre 23
Atlanta 22
Denver 22
Tongling 22
Changsha 21
Lahore 21
Lappeenranta 21
Naples 21
Rimini 21
Washington 21
Wuhan 21
Montreal 20
Shenyang 19
Shenzhen 19
Totale 13.876
Salva come PNG Salva come JPEG
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 333
Monofocal hepatocellular carcinoma: How much does size matter? 295
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 288
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 287
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 278
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 260
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 259
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 259
Pattern of macrovascular invasion in hepatocellular carcinoma 242
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 242
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 237
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 233
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 233
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 232
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 226
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 221
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 221
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 221
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 216
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 213
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 211
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 203
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 199
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 196
Gut Microbiota and Celiac Disease 194
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 194
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 192
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 190
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 189
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 189
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 188
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 184
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 176
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 176
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 172
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 169
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 168
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 168
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 168
Metformin and the Liver: Unlocking the Full Therapeutic Potential 166
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 165
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 165
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 165
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 164
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 164
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 164
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 163
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 159
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 156
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 156
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 153
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 152
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 149
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 149
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 147
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 146
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment 146
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 146
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 146
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 146
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 145
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility 144
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 144
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 144
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 144
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 142
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 140
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Transition of patients with chronic intestinal failure from paediatric to adult center 138
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 138
Malnutrition in hospitalized patients with SARS-CoV-2 infection 137
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 137
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 135
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 135
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 134
Non-invasive tests for the prediction of primary hepatocellular carcinoma 133
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver disease 130
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 128
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 126
Spleen stiffness by ultrasound elastography 126
New insights on portal hypertension's screening in people with cystic fibrosis 125
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 125
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 124
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection 122
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 121
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 120
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 120
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 119
Totale 17.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 0 0 0 0 0 0 241
2021/20222.004 59 43 61 85 173 81 60 109 128 112 836 257
2022/20232.037 157 227 91 263 150 173 83 80 387 71 212 143
2023/2024958 61 134 72 75 92 241 33 65 53 66 36 30
2024/20253.616 134 421 363 243 411 166 284 150 70 352 287 735
2025/202611.355 963 1.223 955 846 784 486 1.413 460 2.191 832 664 538
Totale 22.752